Form 8-K - Current report:
SEC Accession No. 0000914475-25-000120
Filing Date
2025-05-22
Accepted
2025-05-22 16:03:59
Documents
13
Period of Report
2025-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20250521.htm   iXBRL 8-K 47084
5 GRAPHIC nbix-20250521_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-25-000120.txt   213469

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20250521.xsd EX-101.SCH 1791
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20250521_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20250521_pre.xml EX-101.PRE 12514
15 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20250521_htm.xml XML 2716
Mailing Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 25977018
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)